@article{0babf33a32a24536bdc4420414f7afdd,
title = "Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆",
keywords = "cholangiocarcinoma, diagnosis, follow-up, gallbladder cancer, precision medicine, treatment",
author = "A. Vogel and J. Bridgewater and J. Edeline and Kelley, \{R. K.\} and Kl{\"u}mpen, \{H. J.\} and D. Malka and Primrose, \{J. N.\} and L. Rimassa and A. Stenzinger and Valle, \{J. W.\} and \{ESMO Guidelines Committee\} and M. Ducreux",
note = "Funding Information: AV and MD acknowledge the European Reference Network for Rare Solid Adult Cancers (EURACAN) for valuable input and networking. Manuscript editing support was provided by Richard Lutz and Claire Bramley ( ESMO Guidelines staff) and Angela Corstorphine and Sian-Marie Lucas of Kstorfin Medical Communications Ltd (KMC); this support was funded by ESMO . Nathan Cherny, Chair of the ESMO-MCBS Working Group, Urani Dafni, ESMO-MCBS Working Group Member/Frontier Science Foundation Hellas and Giota Zygoura of Frontier Science Foundation Hellas provided review and validation of the ESMO-MCBS scores. Nicola Latino ( ESMO Scientific Affairs staff) provided coordination and support of the ESMO-MCBS scores and Angela Corstorphine and Sian-Marie Lucas of KMC provided medical writing and editing support in the preparation of the ESMO-MCBS table; this support was funded by ESMO . Dr Benedikt Westphalen (member of the ESMO Translational Research and Precision Medicine Working Group) and Dr Svetlana Jezdic ( ESMO Medical Affairs Advisor) provided validation support for ESCAT scores.",
year = "2023",
month = feb,
doi = "10.1016/j.annonc.2022.10.506",
language = "English",
volume = "34",
pages = "127--140",
journal = "Annals of oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "2",
}
SDG 3 Good Health and Well-being